Hikma Pharmaceuticals PLC (HIK) — Tangible Net Worth Ratio
Hikma Pharmaceuticals PLC (HIK) has a Tangible Net Worth Ratio of 67.7% as of June 2025. This metric is calculated by deducting intangible assets (GBX824.00 Million) from net assets (GBX2.55 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Hikma Pharmaceuticals PLC to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hikma Pharmaceuticals PLC Tangible Net Worth Ratio (2002–2024)
This chart shows how Hikma Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 23 annual periods from 2002 to 2024. As of June 2025, the ratio stands at 67.7%, reflecting net assets of GBX2.55 Billion with intangible assets of GBX824.00 Million GBX. See Hikma Pharmaceuticals PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Hikma Pharmaceuticals PLC (2002–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see HIK market cap.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 66.7% | GBX2.32 Billion | GBX774.00 Million | GBX5.13 Billion | ▼ -1.1 pp |
| 2023 | 67.8% | GBX2.21 Billion | GBX712.00 Million | GBX4.68 Billion | ▲ +2.0 pp |
| 2022 | 65.8% | GBX2.15 Billion | GBX735.00 Million | GBX4.47 Billion | ▼ -9.6 pp |
| 2021 | 75.4% | GBX2.47 Billion | GBX607.00 Million | GBX4.37 Billion | ▲ +2.7 pp |
| 2020 | 72.7% | GBX2.15 Billion | GBX587.00 Million | GBX4.13 Billion | ▼ -1.4 pp |
| 2019 | 74.1% | GBX2.13 Billion | GBX552.00 Million | GBX3.93 Billion | ▲ +2.8 pp |
| 2018 | 71.3% | GBX1.70 Billion | GBX487.00 Million | GBX3.50 Billion | ▲ +4.2 pp |
| 2017 | 67.1% | GBX1.53 Billion | GBX503.00 Million | GBX3.39 Billion | ▲ +10.1 pp |
| 2016 | 57.0% | GBX2.41 Billion | GBX1.04 Billion | GBX4.36 Billion | ▼ -19.7 pp |
| 2015 | 76.7% | GBX1.35 Billion | GBX315.00 Million | GBX2.60 Billion | ▲ +0.4 pp |
| 2014 | 76.3% | GBX1.22 Billion | GBX288.00 Million | GBX2.25 Billion | ▼ -7.3 pp |
| 2013 | 83.7% | GBX1.03 Billion | GBX169.00 Million | GBX1.93 Billion | ▲ +3.2 pp |
| 2012 | 80.4% | GBX847.85 Million | GBX166.03 Million | GBX1.73 Billion | ▲ +31.6 pp |
| 2011 | 48.8% | GBX798.63 Million | GBX408.80 Million | GBX1.58 Billion | ▼ -15.3 pp |
| 2010 | 64.1% | GBX750.30 Million | GBX269.12 Million | GBX1.12 Billion | ▲ +1.6 pp |
| 2009 | 62.6% | GBX683.26 Million | GBX255.70 Million | GBX1.02 Billion | ▲ +5.0 pp |
| 2008 | 57.6% | GBX609.00 Million | GBX258.23 Million | GBX966.46 Million | ▲ +18.8 pp |
| 2007 | 38.8% | GBX424.66 Million | GBX259.84 Million | GBX894.04 Million | ▼ -56.9 pp |
| 2006 | 95.7% | GBX349.80 Million | GBX15.02 Million | GBX488.36 Million | ▼ -1.6 pp |
| 2005 | 97.3% | GBX287.48 Million | GBX7.74 Million | GBX397.96 Million | ▲ +0.8 pp |
| 2004 | 96.5% | GBX145.18 Million | GBX5.03 Million | GBX246.48 Million | ▼ -2.8 pp |
| 2003 | 99.3% | GBX60.47 Million | GBX416.00K | GBX117.86 Million | ▲ +0.4 pp |
| 2002 | 99.0% | GBX48.03 Million | GBX503.00K | GBX94.86 Million | — |